Michael P Pignone

Affiliations: 
1996-2016 Internal Medicine University of North Carolina, Chapel Hill, Chapel Hill, NC 
 2016- University of Texas, Austin, Texas 
Area:
Prevention, cardiovascular prevention, cancer prevention, decision making
Google:
"Michael Pignone"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cykert S, Keyserling TC, Pignone M, et al. (2020) A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices. Health Services Research
Gupta S, Coronado GD, Argenbright K, et al. (2020) Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored summit. Ca: a Cancer Journal For Clinicians
Pignone M. (2019) Reconciling Disparate Guidelines: The American College of Physicians Colorectal Cancer Screening Guidance Statement. Annals of Internal Medicine. 171: 671-672
Pignone M. (2019) Optimizing the Physician Workforce for Care of Patients With Type 2 Diabetes. Jama Cardiology. 4: 1175-1177
Adamson AS, Pignone MP. (2019) Eliminating Copayments for Skin Cancer Screening-A Public Health Policy With Insufficient Evidence. Jama Dermatology
Pignone M, DeWalt DA. (2019) More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention. Annals of Internal Medicine. 171: 149
Perestelo-Perez L, Rivero-Santana A, Torres-Castaño A, et al. (2019) Effectiveness of a decision aid for promoting colorectal cancer screening in Spain: a randomized trial. Bmc Medical Informatics and Decision Making. 19: 8
Cykert S, DeWalt DA, Weiner BJ, et al. (2018) A population approach using cholesterol imputation to identify adults with high cardiovascular risk: a report from AHRQ's EvidenceNow initiative. Journal of the American Medical Informatics Association : Jamia
Pignone M, DeWalt DA. (2018) More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention Annals of Internal Medicine. 169: 804-805
Jarmul J, Pletcher MJ, Hassmiller Lich K, et al. (2018) Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis. Circulation. Cardiovascular Quality and Outcomes. 11: e004171
See more...